- AutorIn
- Christoph Haudum
- Lisa Lindheim
- Angelo Ascani
- Christian Trummer
- Angela Horvath
- Julia Münzker
- Barbara Obermayer-Pietsch
- Titel
- Impact of Short-Term Isoflavone Intervention in Polycystic Ovary Syndrome (PCOS) Patients on Microbiota Composition and Metagenomics
- Zitierfähige Url:
- https://nbn-resolving.org/urn:nbn:de:bsz:15-qucosa2-848540
- Quellenangabe
- Nutrients
Erscheinungsjahr: 2020
Jahrgang: 12
Heft: 6
E-ISSN: 2072-6643
Artikelnummer: 1622 - Erstveröffentlichung
- 2020
- Abstract (EN)
- Background: Polycystic ovary syndrome (PCOS) affects 5–20% of women of reproductive age worldwide and is associated with disorders of glucose metabolism. Hormone and metabolic signaling may be influenced by phytoestrogens, such as isoflavones. Their endocrine effects may modify symptom penetrance in PCOS. Equol is one of the most active isoflavone metabolites, produced by intestinal bacteria, and acts as a selective estrogen receptor modulator. Method: In this interventional study of clinical and biochemical characterization, urine isoflavone levels were measured in PCOS and control women before and three days after a defined isoflavone intervention via soy milk. In this interventional study, bacterial equol production was evaluated using the log(equol: daidzein ratio) and microbiome, metabolic, and predicted metagenome analyses were performed. Results: After isoflavone intervention, predicted stool metagenomic pathways, microbial alpha diversity, and glucose homeostasis in PCOS improved resembling the profile of the control group at baseline. In the whole cohort, larger equol production was associated with lower androgen as well as fertility markers. Conclusion: The dynamics in our metabolic, microbiome, and predicted metagenomic profiles underline the importance of external phytohormones on PCOS characteristics and a potential therapeutic approach or prebiotic in the future.
- Andere Ausgabe
- Link zur Erstveröffentlichung
Link: https://doi.org/10.3390/nu12061622 - Freie Schlagwörter (EN)
- polycystic ovary syndrome; isoflavone; equol; microbiome; androgens; glucose metabolism; metagenome
- Klassifikation (DDC)
- 610
- Verlag
- MDPI, Basel
- Version / Begutachtungsstatus
- publizierte Version / Verlagsversion
- URN Qucosa
- urn:nbn:de:bsz:15-qucosa2-848540
- Veröffentlichungsdatum Qucosa
- 20.04.2023
- Dokumenttyp
- Artikel
- Sprache des Dokumentes
- Englisch
- Lizenz / Rechtehinweis
CC BY 4.0